1. All Products
  2. ZINC OXIDE, 15%, ointment, 100g, jar
Public Pricelist

ZINC OXIDE, 15%, ointment, 100g, jar

https://medicalguidelines.msf.org/en/node/1020
https://unicat.msf.org/cat/product/66245
NST DEXTYINO15O1

Valid Article

13 - Dermatological medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
D02AB
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ZINC OXIDE 15% ointment - NST

Please always consider the MSF STD (10% zinc oxide) before ordering a NST.

Therapeutic Action

Skin protector

Indications

Minor skin irritations (eczema)

First degree burns and superficial wounds

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Apply as needed to cleansed and dry skin.

It is recommended to allocate 1 jar per patient.

Prefer the presentation in tubes, which are more practical and hygienic than jars.

Precautions for Use

Do not use as treatment of fungal infections.

Do not use in large surface wounds or burns.

Storage

  • Below 25°C - Protect from sunlight
  • Once the ointment has been exposed to high temperature, the active ingredient is no longer evenly distributed and the ointment must be homogenised before use.
  • Tightly close the jar after each use to prevent contamination.

Description updated and validated by C. Gelosi (OCBA) on 26/04/2023.